Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,251 | -27,519 | -96,423 | -71,936 | -47,967 |
| Depreciation Amortization | 4,335 | 1,824 | 7,163 | 5,295 | 3,476 |
| Income taxes - deferred | -248 | -124 | -497 | -315 | -217 |
| Accounts payable and accrued liabilities | 1,875 | 117 | 150 | 1,493 | -1,067 |
| Other Working Capital | 1,199 | 1,050 | 3,228 | 3,016 | -169 |
| Other Operating Activity | 16,313 | 9,141 | 37,599 | 27,307 | 20,937 |
| Operating Cash Flow | $-31,777 | $-15,511 | $-48,780 | $-35,140 | $-25,007 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 32,068 | 7,822 | 142,867 | 111,700 | 94,022 |
| PPE Investments | -7,394 | -4,902 | -34,815 | -23,382 | -12,665 |
| Purchase Of Investment | -361 | N/A | -8,500 | -8,500 | -8,500 |
| Investing Cash Flow | $24,313 | $2,920 | $99,552 | $79,818 | $72,857 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -198 | -65 | -19,932 | -19,868 | -4,920 |
| Common Stock Issued | 35 | 23 | 1,215 | 1,192 | 1,191 |
| Common Stock Repurchased | 0 | N/A | -15,227 | -12,456 | -12,456 |
| Other Financing Activity | -123 | -43 | -1,039 | -709 | -709 |
| Financing Cash Flow | $-286 | $-85 | $-34,983 | $-31,841 | $-16,894 |
| Beginning Cash Position | 24,051 | 24,051 | 8,262 | 8,262 | 8,262 |
| End Cash Position | 16,301 | 11,375 | 24,051 | 21,099 | 39,218 |
| Net Cash Flow | $-7,750 | $-12,676 | $15,789 | $12,837 | $30,956 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,777 | -15,511 | -48,780 | -35,140 | -25,007 |
| Capital Expenditure | -7,394 | -4,902 | -34,815 | -23,382 | -12,665 |
| Free Cash Flow | -39,171 | -20,413 | -83,595 | -58,522 | -37,672 |